{"id":370463,"date":"2025-12-20T16:00:51","date_gmt":"2025-12-20T10:30:51","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=370463"},"modified":"2025-12-20T16:21:47","modified_gmt":"2025-12-20T10:51:47","slug":"shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/","title":{"rendered":"Shardul Amarchand Mangaldas &#038; Co. advises Nephrocare Health Services Limited on its Initial Public Offering"},"content":{"rendered":"<div style=\"text-align: justify; line-height: 150%;\">\n<p style=\"margin-bottom: 3%;\"><span style=\"font-weight: bold;\">New Delhi | 18th December 2025:<\/span> Shardul Amarchand Mangaldas &amp; Co. (SAM) advised Nephrocare Health Services Limited (&#8220;Nephroplus&#8221;) on its initial public offering aggregating to approximately US$ 95.99 million (&#8377; 8,710.48 million), comprising a fresh issue of &#8377; 3,534.05 million and an offer for sale of &#8377; 5,176.43 million.<\/p>\n<p style=\"margin-bottom: 3%;\">SAM acted as legal counsel to Nephroplus on Indian law aspects of the transaction, advising on the drafting and regulatory compliance for the IPO, including coordination with multiple domestic and international stakeholders and supporting the company through the prospectus filing and listing process.<\/p>\n<p style=\"margin-bottom: 3%;\">The SAM team was led by Prashant Gupta, National Practice Head &#8212; Capital Markets and Devi Prasad Patel, Partner; and assisted by Divya Dhawan, Associate; Satakshi N. Dixit, Associate; and Arjun Bhatia, Associate.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p style=\"font-style: italic;\">Shardul Amarchand Mangaldas advised Nephrocare Health Services Limited (Nephroplus) on its initial public offering aggregating to approximately US$ 95.99 million, covering Indian law, regulatory compliance, and prospectus and listing support.<\/p>\n","protected":false},"author":67011,"featured_media":370471,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[92619,95308,95358,95355,95356,95359,95357,94204,46701],"class_list":["post-370463","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-capital-markets-india","tag-healthcare-ipo-india","tag-indian-ipo-legal-advisors","tag-nephrocare-health-services-ipo","tag-nephroplus-ipo","tag-public-issue-india","tag-sam-ipo-advisory","tag-sebi-ipo-compliance","tag-shardul-amarchand-mangaldas"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.4 (Yoast SEO v26.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Shardul Amarchand Mangaldas Advises Nephrocare (Nephroplus) on IPO | SCC Times<\/title>\n<meta name=\"description\" content=\"Shardul Amarchand Mangaldas advised Nephrocare Health Services (Nephroplus) on its US$ 95.99 million initial public offering.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shardul Amarchand Mangaldas advises Nephrocare Health Services Limited on its Initial Public Offering\" \/>\n<meta property=\"og:description\" content=\"Shardul Amarchand Mangaldas advised Nephrocare Health Services (Nephroplus) on its US$ 95.99 million initial public offering.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-20T10:30:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-20T10:51:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/blog-22-13.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Shardul Amarchand Mangaldas &amp; Co. advises Nephrocare Health Services Limited on its Initial Public Offering\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/\",\"name\":\"Shardul Amarchand Mangaldas Advises Nephrocare (Nephroplus) on IPO | SCC Times\",\"isPartOf\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/blog-22-13.webp\",\"datePublished\":\"2025-12-20T10:30:51+00:00\",\"dateModified\":\"2025-12-20T10:51:47+00:00\",\"author\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\"},\"description\":\"Shardul Amarchand Mangaldas advised Nephrocare Health Services (Nephroplus) on its US$ 95.99 million initial public offering.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#primaryimage\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/blog-22-13.webp\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/blog-22-13.webp\",\"width\":886,\"height\":590,\"caption\":\"Nephrocare Nephroplus IPO\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.scconline.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shardul Amarchand Mangaldas &#038; Co. advises Nephrocare Health Services Limited on its Initial Public Offering\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\",\"url\":\"https:\/\/www.scconline.com\/blog\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.scconline.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shardul Amarchand Mangaldas Advises Nephrocare (Nephroplus) on IPO | SCC Times","description":"Shardul Amarchand Mangaldas advised Nephrocare Health Services (Nephroplus) on its US$ 95.99 million initial public offering.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/","og_locale":"en_US","og_type":"article","og_title":"Shardul Amarchand Mangaldas advises Nephrocare Health Services Limited on its Initial Public Offering","og_description":"Shardul Amarchand Mangaldas advised Nephrocare Health Services (Nephroplus) on its US$ 95.99 million initial public offering.","og_url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2025-12-20T10:30:51+00:00","article_modified_time":"2025-12-20T10:51:47+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/blog-22-13.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_title":"Shardul Amarchand Mangaldas & Co. advises Nephrocare Health Services Limited on its Initial Public Offering","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/","url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/","name":"Shardul Amarchand Mangaldas Advises Nephrocare (Nephroplus) on IPO | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/blog-22-13.webp","datePublished":"2025-12-20T10:30:51+00:00","dateModified":"2025-12-20T10:51:47+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"description":"Shardul Amarchand Mangaldas advised Nephrocare Health Services (Nephroplus) on its US$ 95.99 million initial public offering.","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/blog-22-13.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/blog-22-13.webp","width":886,"height":590,"caption":"Nephrocare Nephroplus IPO"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/shardul-amarchand-mangaldas-advises-nephrocare-nephroplus-ipo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Shardul Amarchand Mangaldas &#038; Co. advises Nephrocare Health Services Limited on its Initial Public Offering"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/blog-22-13.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":370347,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/cyril-amarchand-mangaldas-advises-ifc-nephrocare-health-services-ipo\/","url_meta":{"origin":370463,"position":0},"title":"Cyril Amarchand Mangaldas Advises IFC on Nephrocare Health Services Limited IPO","author":"Editor","date":"December 20, 2025","format":false,"excerpt":"The IPO comprised a fresh issue and an offer for sale, with IFC divesting part of its shareholding. Nephrocare\u2019s equity shares were listed on Indian stock exchanges on 17 December 2025.","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"CAM Advises IFC Nephrocare","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Advises-IFC-Nephrocare.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Advises-IFC-Nephrocare.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Advises-IFC-Nephrocare.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Advises-IFC-Nephrocare.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":366282,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/11\/shardul-amarchand-mangaldas-advises-on-lenskart-ipo-2025\/","url_meta":{"origin":370463,"position":1},"title":"Shardul Amarchand Mangaldas Advises Book Running Lead Managers on Lenskart&#8217;s \u20b97,278 Crore IPO","author":"Editor","date":"November 11, 2025","format":false,"excerpt":"Shardul Amarchand Mangaldas & Co. advised the Book Running Lead Managers on Lenskart\u2019s \u20b97,278 crore IPO, comprising a \u20b92,150 crore fresh issue and a \u20b95,128 crore offer for sale.","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Lenskart IPO 2025","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/Lenskart-IPO-2025.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/Lenskart-IPO-2025.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/Lenskart-IPO-2025.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/Lenskart-IPO-2025.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":376005,"url":"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/18\/aye-finance-ipo-sam-capital-markets\/","url_meta":{"origin":370463,"position":2},"title":"Shardul Amarchand Mangaldas &amp; Co.  Advises Aye Finance Limited on &#8377;1,010 Crore Initial Public Offering","author":"Editor","date":"February 18, 2026","format":false,"excerpt":"Shardul Amarchand Mangaldas advised Aye Finance Limited on its \u20b91,010 crore initial public offering comprising a fresh issue and offer for sale.","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Aye Finance IPO","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/Aye-Finance-IPO.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/Aye-Finance-IPO.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/Aye-Finance-IPO.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/Aye-Finance-IPO.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":296480,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/07\/11\/sam-advises-idea-forge-technology-limited-on-the-initial-public-offering-of-equity-shares-aggregating-to-567-24-crore\/","url_meta":{"origin":370463,"position":3},"title":"SAM advises ideaForge Technology Limited on the Initial Public Offering of equity shares aggregating to \u20b9 567.24 crore","author":"Bhumika Indulia","date":"July 11, 2023","format":false,"excerpt":"10 July 2023| New Delhi: Shardul Amarchand Mangaldas advised ideaForge Technology Limited on the Initial Public Offering of 8,441,764 equity shares on the Indian Stock Exchange Market. This includes issuance of fresh 3,572,052 equity shares aggregating to \u20b9 2,400.00 million and an offer for sale of 4,869,712 equity shares aggregating\u2026","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"ideaforge technology limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/07\/ideaforge-technology-limited.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/07\/ideaforge-technology-limited.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/07\/ideaforge-technology-limited.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/07\/ideaforge-technology-limited.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":375975,"url":"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/18\/fractal-analytics-ipo-sam-capital-markets\/","url_meta":{"origin":370463,"position":4},"title":"Shardul Amarchand Mangaldas &amp; Co. Advises Fractal Analytics on \u20b928,339 Million Initial Public Offering","author":"Editor","date":"February 18, 2026","format":false,"excerpt":"Shardul Amarchand Mangaldas advised Fractal Analytics on its \u20b928,339 million initial public offering comprising a fresh issue and offer for sale.","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Fractal Analytics IPO","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/Fractal-Analytics-IPO.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/Fractal-Analytics-IPO.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/Fractal-Analytics-IPO.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/Fractal-Analytics-IPO.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":379631,"url":"https:\/\/www.scconline.com\/blog\/post\/2026\/03\/28\/raajmarg-infra-invit-ipo-60000-million-sam\/","url_meta":{"origin":370463,"position":5},"title":"Shardul Amarchand Mangaldas &amp; Co. Advises on INR 60,000 Million IPO by Raajmarg Infra Investment Trust","author":"Editor","date":"March 28, 2026","format":false,"excerpt":"Shardul Amarchand Mangaldas & Co. advised book running lead managers on the INR 60,000 million IPO of Raajmarg Infra Investment Trust, India\u2019s largest road sector public offering.","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Raajmarg Infra InvIT IPO","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/03\/Raajmarg-Infra-InvIT-IPO.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/03\/Raajmarg-Infra-InvIT-IPO.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/03\/Raajmarg-Infra-InvIT-IPO.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/03\/Raajmarg-Infra-InvIT-IPO.webp?resize=700%2C400&ssl=1 2x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/370463","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=370463"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/370463\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/370471"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=370463"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=370463"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=370463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}